Introduction: In this study, coagulation and fibrinolysis parameters their association with disease severity were investigated in coronavirus (COVID-19) patients. Materials Methods: COVID-19 patients (n = 446) admitted to our institute between 21 February 2021 17 March 2022, recruited. Clinical data staging collected from all Blood samples analyzed for several of coagulation, including alpha-2-...

Background: Plasminogen activator inhibitor-1 (PAI-1) is a glycoprotein with inhibitory effects on the formation of plasmin from plasminogen by plasminogen activator. Thus, it prevents clot lysis in vessel walls. Several evidences prove the relationship between coronary artery disease and response to fibrinolytic therapy in patients with myocardial infarction with PAI-1 level. Opium addiction i...